Role of [

ABC guidelines Breast cancer EANM-SNMMI guidelines ESMO guidelines FDG-PET/CT NCCN guidelines

Journal

Breast (Edinburgh, Scotland)
ISSN: 1532-3080
Titre abrégé: Breast
Pays: Netherlands
ID NLM: 9213011

Informations de publication

Date de publication:
12 Sep 2024
Historique:
received: 01 07 2024
revised: 29 08 2024
accepted: 07 09 2024
medline: 21 9 2024
pubmed: 21 9 2024
entrez: 20 9 2024
Statut: aheadofprint

Résumé

The recently released EANM/SNMMI guideline, endorsed by several important clinical and imaging societies in the field of breast cancer (BC) care (ACR, ESSO, ESTRO, EUSOBI/ESR, EUSOMA), emphasized the role of [ The EANM/SNMMI guideline was based on a systematic literature search and the AGREE tool. The level of evidence was determined according to NICE criteria, and 85 % agreement or higher was reached regarding each statement. Comparisons with NCCN, ESMO and ABC guidelines were examined for specific clinical scenarios in patients with early stage through advanced and metastatic BC. Regarding initial staging of patients with NST BC, [ The recently released EANM/SNMMI guideline reinforces the role of [

Identifiants

DOI: 10.1016/j.breast.2024.103806 PMID: 39303572
pubmed: 39303572
pii: S0960-9776(24)00137-1
doi: 10.1016/j.breast.2024.103806
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

103806

Informations de copyright

Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved.

Auteurs

David Groheux (D)

Department of Nuclear Medicine, Saint-Louis Hospital, Paris, France; University Paris-Diderot, INSERM, U976, Paris, France; Centre d'Imagerie Radio-Isotopique (CIRI), La Rochelle, France. Electronic address: dgroheux@yahoo.fr.

Sofia C Vaz (SC)

Department of Nuclear Medicine and Radiopharmacology, Champalimaud Clinical Center, Champalimaud Foundation, Lisbon, Portugal; Department of Radiology, Leiden University Medical Center, Leiden, the Netherlands.

Philip Poortmans (P)

Department of Radiation Oncology, Iridium Netwerk, Belgium; Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk-Antwerp, Belgium.

Ritse M Mann (RM)

Department of Radiology, Radboud umc, Nijmegen, the Netherlands.

Gary A Ulaner (GA)

Department of Molecular Imaging and Therapy, Hoag Family Cancer Institute, Newport Beach, CA, United States; Departments of Radiology and Translational Genomics, University of Southern California, Los Angeles, CA, United States.

Gary J R Cook (GJR)

Department of Cancer Imaging, King's College London, London, UK; King's College London and Guy's & St Thomas' PET Centre, London, UK; School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK.

Elif Hindié (E)

Department of Nuclear Medicine, Bordeaux University Hospital, Bordeaux, France.

John Patrick Pilkington Woll (JP)

Department of PET-CT, Clinica Delgado AUNA, Lima, Peru.

Heather Jacene (H)

Dana-Farber Cancer Institute/Brigham and Women's Hospital, and Harvard Medical School, United States.

Isabel T Rubio (IT)

Department of Breast Surgical Oncology, Clinica Universidad de Navarra, Madrid, Cancer Center Clinica Universidad de Navarra, Spain.

Marie-Jeanne Vrancken Peeters (MJ)

Department of Surgical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Surgery, Amsterdam University Medical Center, Amsterdam, the Netherlands.

Elizabeth H Dibble (EH)

Department of Diagnostic Imaging, The Warren Alpert Medical School of Brown University, Providence, RI, United States.

Lioe-Fee de Geus-Oei (LF)

Department of Radiology, Leiden University Medical Center, Leiden, the Netherlands; Biomedical Photonic Imaging Group, University of Twente, Enschede, the Netherlands; Department of Radiation Science & Technology, Delft University of Technology, Delft, the Netherlands.

Stephanie L Graff (SL)

Lifespan Cancer Institute, Providence, RI, United States; Legorreta Cancer Center at Brown University, Providence, RI, United States.

Fatima Cardoso (F)

Breast Unit, Champalimaud Clinical Center, Champalimaud Foundation, Lisbon, Portugal.

Classifications MeSH